These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10570484)

  • 21. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of tetanus neurotoxin insensitive vesicle-associated membrane protein (TI-VAMP) in vesicular transport mediating neurite outgrowth.
    Martinez-Arca S; Alberts P; Zahraoui A; Louvard D; Galli T
    J Cell Biol; 2000 May; 149(4):889-900. PubMed ID: 10811829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redistribution of presynaptic proteins during alpha-latrotoxin-induced release of neurotransmitter and membrane retrieval at the frog neuromuscular junction.
    Boudier JA; Martin-Moutot N; Boudier JL; Iborra C; Takahashi M; Seagar MJ
    Eur J Neurosci; 1999 Oct; 11(10):3449-56. PubMed ID: 10564353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Globular tail of myosin-V is bound to vamp/synaptobrevin.
    Ohyama A; Komiya Y; Igarashi M
    Biochem Biophys Res Commun; 2001 Feb; 280(4):988-91. PubMed ID: 11162623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calmodulin and lipid binding to synaptobrevin regulates calcium-dependent exocytosis.
    Quetglas S; Iborra C; Sasakawa N; De Haro L; Kumakura K; Sato K; Leveque C; Seagar M
    EMBO J; 2002 Aug; 21(15):3970-9. PubMed ID: 12145198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes.
    Caccin P; Rossetto O; Rigoni M; Johnson E; Schiavo G; Montecucco C
    FEBS Lett; 2003 May; 542(1-3):132-6. PubMed ID: 12729912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin.
    Capogna M; McKinney RA; O'Connor V; Gähwiler BH; Thompson SM
    J Neurosci; 1997 Oct; 17(19):7190-202. PubMed ID: 9295365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ; Stafford RG
    Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.
    Yamasaki S; Binz T; Hayashi T; Szabo E; Yamasaki N; Eklund M; Jahn R; Niemann H
    Biochem Biophys Res Commun; 1994 Apr; 200(2):829-35. PubMed ID: 7910017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitatory effect of glutamate exocytosis from rat cerebrocortical nerve terminals by alpha-tocopherol, a major vitamin E component.
    Yang TT; Wang SJ
    Neurochem Int; 2008 May; 52(6):979-89. PubMed ID: 18037536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.
    Schiavo G; Rossetto O; Montecucco C
    Semin Cell Biol; 1994 Aug; 5(4):221-9. PubMed ID: 7994006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell entry strategy of clostridial neurotoxins.
    Binz T; Rummel A
    J Neurochem; 2009 Jun; 109(6):1584-95. PubMed ID: 19457120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time measurements of vesicle-SNARE recycling in synapses of the central nervous system.
    Sankaranarayanan S; Ryan TA
    Nat Cell Biol; 2000 Apr; 2(4):197-204. PubMed ID: 10783237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial organization and dynamic properties of neurotransmitter release sites in the enteric nervous system.
    Vanden Berghe P; Klingauf J
    Neuroscience; 2007 Mar; 145(1):88-99. PubMed ID: 17197103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
    Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
    J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion.
    Hu K; Carroll J; Fedorovich S; Rickman C; Sukhodub A; Davletov B
    Nature; 2002 Feb; 415(6872):646-50. PubMed ID: 11832947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tetanus neurotoxin-sensitive and insensitive routes to and from the plasma membrane: fast and slow pathways?
    Proux-Gillardeaux V; Rudge R; Galli T
    Traffic; 2005 May; 6(5):366-73. PubMed ID: 15813747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
    Hanson MA; Stevens RC
    Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.